Navigation Links
FDAnews Announces — FDAnews Expert Insight Series: Device Regulation Under Gottlieb & Trump Webinar, Oct. 12, 2017
Date:9/25/2017

FDAnews Expert Insight Series:
Device Regulation Under Gottlieb & Trump
**An FDAnews Webinar**
Oct. 12, 2017 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/deviceregulation    

FDA Commissioner Scott Gottlieb is off to a running start. Just look what’s happened in four short months:

  •     The first device recall over cybersecurity (a pacemaker)
  •     Final guidance re: device interoperability
  •     New guidance re: use of real-world experience in device approvals
  •     New small-business guidance re: applying for lower user fees
  •     Clarification of early feasibility study program for early-stage devices

And Gottlieb is just getting started.

  •     His big-picture approach to device regulation has yet to emerge, as does
  •     What role patients will play in device development and approval, and
  •     How the FDA will sort out knotty issues surrounding combination products.

FDAnews’s expert panelists are ready with answers.

Mark the calendar for Thursday, Oct. 12 and Part II of the standout FDAnews Expert Insight Series. Attendees will hear from five of the most insightful FDA experts at work today as they track the path of the Gottlieb FDA and medical device regulation:

  •     Wayne Pines, chief FDA spokesman for seven years. Mr. Pines was FDA Alumnus of the Year (2004). He now advises FDA-regulated clients on crisis communications.
  •     Peter Pitts, top policy adviser to FDA Commissioner McClellan among other FDA leadership positions. While at the FDA Mr. Pitts worked directly with Scott Gottlieb. He now heads the Center for Medicine in the Public Interest.
  •     Marc Scheineson Esq., partner, Alston & Bird LLP. As FDA associate commissioner for legislative affairs, Mr. Scheineson was active on Rx user fees, debarment, medical device amendments and nutrition labeling, among other innovative policies. He has also served as a counsel to the House Ways & Means Committee.
  •     Jill Hartzler Warner Esq., VP-Regulatory Policy, Catalyst Healthcare Consulting. Over 30+ years as an international regulatory policy specialist, Ms. Warner held FDA leadership roles including Associate Commissioner, Senior Advisor, and Associate Chief Counsel. She oversaw policy on orphan products development, combination products, pediatric therapeutics, good clinical practice, regenerative medicine, and advisory committee oversight and management, among other responsibilities.
  •     Dan Kracov Esq., Partner, Arnold & Porter Kaye Scholer LLP. As one of the nation’s foremost FDA legal practitioners, Mr. Kracov is known for expertise in development, approval and marketing of FDA-regulated products — not only drugs and devices but also foods, dietary supplements and cosmetics.

The topic of the day is devices, but don’t be surprised if panelists range beyond it to matters affecting other FDA-regulated health science firms. Plan to listen in even if devices aren’t a main concern. Devicemakers will be participating Thursday, Nov. 16 for Part III, when drugs and biologics are on the agenda. And everyone is advised to mark their calendars for the final session Thursday, Dec. 14: Global Regulation and a Look Ahead.

Who Will Benefit:

  •     Executive Suite
  •     Planning/Strategy
  •     Regulatory Affairs
  •     Legal Counsel
  •     Marketing/Sales
  •     QA/QR/QC
  •     Manufacturing – GMP/QSR/GCP
  •     Inspections/Audits
  •     Clinical Trial Design
  •     Data Integrity
  •     Postmarket Safety
  •     Submissions/Approvals
  •     R&D
  •     Commercial Operations

Webinar Details:
FDAnews Expert Insight Series:
Device Regulation Under Gottlieb & Trump
**An FDAnews Webinar**
Oct. 12, 2017 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/deviceregulation        

Tuition:
Attend 1 session: $287 per site
Attend 4 sessions: $487 per site

Easy Ways to Register:
Online:     http://www.fdanews.com/deviceregulation                                                                                        
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Read the full story at http://www.prweb.com/releases/FDAnews/deviceregulation/prweb14732801.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. FDAnews Announces: Flawless FDA Inspection Handling and Response Preconference Workshop for the 12th Annual FDA Inspections Summit, November 1-3, 2017, Bethesda, MD
2. FDAnews Announces — Process Capability Indices for Medical Device Manufacturers Webinar, Sept. 26, 2017
3. FDAnews Announces — New Management Report — Promotional Communication: Keeping Up with FDA’s Off-Label Use Policy
4. FDAnews Announces: Early Bird Pricing Ends Sept. 22 for Medical Device Supplier Quality Management, Oct. 17-18, 2017, Cambridge, MA
5. FDAnews Announces: Early Bird Pricing Ends Sept. 22 for Conducting Advanced Root Cause Analysis CAPA Investigations, Oct. 23-24, 2017, Arlington, VA
6. FDAnews Announces — New Management Report — Biological Risk Evaluation and Management for Medical Devices
7. FDAnews Announces — FDA: When it Comes to 3D Printing, the Future is Already Here Webinar, Sponsored by Dassault Systemes, Sept. 28, 2017
8. FDAnews Announces: No More 483s — QSIT Secrets to Assure Clean Inspections Preconference Workshop for the 12th Annual FDA Inspections Summit, November 1-3, 2017
9. FDAnews Announces — Advertising Medical Products: Real-Life Scenarios that Illustrate What You Can and Cannot Say Webinar, Sept. 19, 2017
10. FDAnews Announces — New Management Report — Complaint Management for Devicemakers: From Receiving and Investigating to Analyzing Trends
11. FDAnews Announces: Medical Device Supplier Quality Management: Are You and Your Suppliers Compliant?, Oct. 17-18, 2017, Cambridge, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: